CHOSA has carried out a directed issue of SEK 5,58 million to fund KOL-initiated DRP validation studies and to increase business development activities
Regulatory press release: The board of CHOSA Oncology AB (publ) (CHOSA or the Company) has today, 3. April 2024, performed a directed issue of 6 070 233 shares at a price of SEK 0,92 per share. The subscription price per sha...[läs mer]